Clinical trials
Glomerulonephritis trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 5 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Charite University, Berlin, Germany | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Alpine Immune Sciences Inc, A Subsidiary of Vertex | 1 |
| Biohaven Therapeutics Ltd. | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| HI-Bio, A Biogen Company | 1 |
| Human Genome Sciences Inc., a GSK Company | 1 |
| Imperial College Healthcare NHS Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glomerulonephritis | 19 |
| Glomerulonephritis, IGA | 9 |
| Kidney Diseases | 8 |
| Autoimmune Diseases | 4 |
| Nephritis | 4 |
| Renal Insufficiency, Chronic | 4 |
| Immune System Diseases | 3 |
| Lupus Nephritis | 3 |
| Proteinuria | 3 |
| Urologic Diseases | 3 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.